...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Interdependent regulation of afferent renal nerve activity and renal function: role of transient receptor potential vanilloid type 1, neurokinin 1, and calcitonin gene-related peptide receptors.
【24h】

Interdependent regulation of afferent renal nerve activity and renal function: role of transient receptor potential vanilloid type 1, neurokinin 1, and calcitonin gene-related peptide receptors.

机译:肾传入神经活动和肾功能的相互调节:短暂受体电位类香草素1型,神经激肽1和降钙素基因相关肽受体的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Our previous studies have shown that the activation of the transient receptor potential vanilloid type 1 (TRPV1) expressed in the renal pelvis leads to an increase in ipsilateral afferent renal nerve activity (ARNA) and contralateral renal excretory function, but the molecular mechanisms of TRPV1 action are largely unknown. This study tests the hypothesis that activation of receptors of neurokinin 1 (NK1) or calcitonin gene-related peptide (CGRP) by endogenously released substance P (SP) or CGRP following TRPV1 activation, respectively, governs TRPV1-induced increases in ARNA and renal excretory function. Capsaicin (CAP; 0.04, 0.4, and 4 nM), a selective TRPV1 agonist, administered into the renal pelvis dose-dependently increased ARNA. CAP (4 nM)-induced increases in ipsilateral ARNA or contralateral urine flow rate (Uflow) and urinary sodium excretion (UNa) were abolished by capsazepine (CAPZ), a selective TRPV1 antagonist, or 2-[1-imino-2-(2-methoxyphenyl)ethyl]-7,7-diphenyl-4-perhydroisoindolone (3aR,7aR) (RP67580) or cis-2-(diphenylmethyl)-N-[(2-iodophenyl)-methyl]-1 azabicyclo[2.2.2]octan-3-amine (L703,606), selective NK1 antagonists, but not by CGRP8-37, a selective CGRP receptor antagonist. Both SP (7.4 nM) and CGRP (0.13 muM) increased ARNA, Uflow, or UNa, and increases in these parameters induced by CGRP but not SP were abolished by CAPZ. CAP at 4 nM perfused into the renal pelvis caused the release of SP and CGRP, which was blocked by CAPZ but not by RP67580, L703,606, or CGRP8-37. Immunofluorescence results showed that NK1 receptors were expressed in sensory neurons in dorsal root ganglion and sensory nerve fibers innervating the renal pelvis. Taken together, our data indicate that NK1 activation induced by SP release upon TRPV1 activation governs TRPV1 function and that a TRPV1-dependent mechanism is operant in CGRP action.
机译:我们以前的研究表明,肾盂中表达的瞬态受体电位类香草素1型(TRPV1)的激活导致同侧传入肾神经活性(ARNA)和对侧肾脏排泄功能的增加,但是TRPV1作用的分子机制在很大程度上是未知的。这项研究检验了以下假设:TRPV1激活后,内源性释放的物质P(SP)或CGRP分别激活神经激肽1(NK1)或降钙素基因相关肽(CGRP)的受体,可控制TRPV1诱导的ARNA和肾排泄物的增加。功能。辣椒素(CAP; 0.04、0.4和4 nM),一种选择性的TRPV1激动剂,以剂量依赖性方式增加到肾盂的ARNA中。通过选择性TRPV1拮抗剂辣椒碱(CAPZ)或2- [1-1-亚氨基-2-(-)消除了CAP(4 nM)引起的同侧ARNA或对侧尿流率(Uflow)和尿钠排泄(UNa)的增加。 2-甲氧基苯基)乙基] -7,7-二苯基-4-全氢异吲哚酮(3aR,7aR)(RP67580)或顺-2-(二苯基甲基)-N-[(2-碘苯基)-甲基] -1氮杂双环[2.2。 2] octan-3-amine(L703,606),选择性NK1拮抗剂,但不被CGRP8-37(选择性CGRP受体拮抗剂)使用。 SP(7.4 nM)和CGRP(0.13μM)均增加了ARNA,Uflow或UNa,而CAPZ取消了由CGRP诱导而不是由SP诱导的这些参数的增加。在肾脏骨盆中灌注4 nM的CAP导致SP和CGRP的释放,这被CAPZ阻止,但未被RP67580,L703,606或CGRP8-37阻止。免疫荧光结果显示,NK1受体在背根神经节和支配肾盂的感觉神经纤维的感觉神经元中表达。两者合计,我们的数据表明由TRPV1激活的SP释放诱导的NK1激活支配着TRPV1的功能,并且依赖TRPV1的机制在CGRP作用中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号